Ind-Swift Laboratories Limited has scheduled an Extraordinary General Meeting (EGM) on August 05, 2026, to seek shareholder approval for the preferential allotment of up to 70,00,000 fully convertible warrants to Essix Biosciences Limited, a promoter group entity. The warrants are priced at ₹196 each, aggregating to ₹137.2 crore, and will convert into equity shares within 18 months of allotment. The meeting will also consider the re-appointment of Sh. Rajinder Kumar Gupta as an Independent Director and the alteration of the Articles of Association.

The board meeting held on July 10, 2026, approved the issuance of warrants to raise funds for business expansion, working capital requirements, and general corporate purposes. The preferential issue is subject to the approval of shareholders by way of a special resolution. The company has engaged CDSL as the e-voting agency, with remote e-voting commencing on August 02, 2026, at 9:00 A.M. IST and concluding on August 04, 2026, at 5:00 P.M. IST. The notice of the EGM was dispatched electronically on July 14, 2026, and newspaper advertisements confirming the dispatch were published in Financial Express and Jansatta on July 15, 2026.

Key Issue Details

E-Voting Schedule

Shareholders can cast their votes remotely or during the EGM via Video Conferencing (VC) and Other Audio-Visual Means (OAVM). The voting rights are determined based on shareholding as of July 29, 2026, the cut-off date. Members attending via VC/OAVM will be counted for the purpose of Quorum under Section 103 of the Companies Act, 2013. The notice is available on the company's website at www.indswiftgroup.com and the websites of BSE Limited and National Stock Exchange of India Limited. Shareholders holding shares in physical form must send a request to the RTA, Alankit Assignments Limited, in the prescribed Form ISR-1 to register their email address.

Ind-Swift Laboratories Limited accepted the resignation of Mr. Prabhat Khurana as Independent Director, effective from the close of business hours on June 22, 2026. The resignation was submitted via email on June 22, 2026, citing personal and professional commitments as the reason for his departure. The Board of Directors recorded its appreciation for the guidance provided by Mr. Khurana during his association with the company.

Resignation Details

Mr. Prabhat Khurana resigned from his position as Independent Director, including his membership on all Board Committees. He confirmed that there are no material reasons for his resignation other than those stated in his letter. The intimation was made to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Disclosures and Regulatory Compliance

The company disclosed that Mr. Khurana does not hold directorships in any other listed entities. The resignation letter and detailed reasons were provided as annexures to the regulatory filing. The company confirmed that all necessary statutory and regulatory formalities would be completed regarding the change.